STAT1 and neoplasm: We consistently found that treating NB4 cells with butyrate causes a significant downregulation of the mRNA levels of HLA-A and HLA-B (Supplemental Figure 5.2). Truly, the cellular context may determine whether STAT1 acts as tumor promoter or as a tumor suppressor.